|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/12 | |
| C12N 15/62 | |||
| C07K 14/71 | |||
| A61K 38/17 |
| (11) | Patento numeris | 2318529 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09791148.1 |
| Europos patento paraiškos padavimo data | 2009-08-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-05-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/052704 |
| Data | 2009-08-04 |
| (87) | Numeris | WO 2010/017198 |
| Data | 2010-02-11 |
| (30) | Numeris | Data | Šalis |
| 86121 P | 2008-08-04 | US |
| (72) |
MARSHALL, Shannon, US
CHARYCH, Deborah, H., US
SADRA, Ali, US
|
| (73) |
Five Prime Therapeutics, Inc.,
Two Corporate Drive, South San Francisco, CA 94080,
US
|
| (54) | FGFR EXTRACELLULAR DOMAIN ACIDIC REGION MUTEINS |
| FGFR EXTRACELLULAR DOMAIN ACIDIC REGION MUTEINS |